Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics, Inc. Announces First Patient Enrolled in the Registration-Directed UNITY-DLBCL Phase 2b Trial
Jun 7, 2016
PDF 283.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Long-Term Follow-up of TGR-1202 Demonstrates a Differentiated Safety Profile and High Response Rates in CLL and NHL in Data Presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Jun 6, 2016
PDF 338.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Recaps Schedule of Clinical Data Presentations at the 52nd Annual Meeting of the American Society of Clinical Oncology
Jun 2, 2016
PDF 325.7 KB Add to Briefcase
View Summary TG Therapeutics Enters into a Global Collaboration to Develop and Commercialize Novel BET Inhibitors Developed by Jubilant Biosys for the Treatment of Hematological Malignancies
May 27, 2016
PDF 286.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 21st European Hematology Association Annual Congress
May 20, 2016
PDF 326.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentation at the Upcoming 52nd Annual Meeting of the American Society of Clinical Oncology
May 18, 2016
PDF 326.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces First Quarter 2016 Financial Results and Business Update
May 10, 2016
PDF 293.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on First Quarter 2016 Financial Results and Business Update
May 9, 2016
PDF 280.2 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Launches First Clinical Trial in Multiple Sclerosis (MS) for TG-1101 (Ublituximab)
May 3, 2016
PDF 284.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Pre-Clinical Data Presentation on TGR-1202 Demonstrating Differentiated Effects on T-Cells
Apr 18, 2016
PDF 286.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TG-1101 in the United States
Apr 13, 2016
PDF 16.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Pre-Clinical Data Presentation on TGR-1202 at the 2016 American Association for Cancer Research (AACR) Annual Meeting
Mar 17, 2016
PDF 326.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 28th Annual ROTH Conference
Mar 11, 2016
PDF 12.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2015 Financial Results and Business Update
Mar 7, 2016
PDF 295.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at Upcoming Investment Conferences
Mar 7, 2016
PDF 13.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2015 Financial Results and Business Update
Mar 4, 2016
PDF 13.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TGR-1202 in the United States
Feb 23, 2016
PDF 16.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 18th Annual BIO CEO & Investor Conference
Feb 3, 2016
PDF 12.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Sets Corporate Goals and Objectives for 2016
Jan 19, 2016
PDF 18.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 11, 2016
PDF 12.9 KB Add to Briefcase
Showing 61-80 of 195 Page: 1 2 3 4 5 6 7 8 ... 10  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase